- News Home
17 April 2014 12:48 pm ,
Vol. 344 ,
Officials last week revealed that the U.S. contribution to ITER could cost $3.9 billion by 2034—roughly four times the...
An experimental hepatitis B drug that looked safe in animal trials tragically killed five of 15 patients in 1993. Now,...
Using the two high-quality genomes that exist for Neandertals and Denisovans, researchers find clues to gene activity...
A new report from the Intergovernmental Panel on Climate Change (IPCC) concludes that humanity has done little to slow...
Astronomers have discovered an Earth-sized planet in the habitable zone of a red dwarf—a star cooler than the sun—500...
Three years ago, Jennifer Francis of Rutgers University proposed that a warming Arctic was altering the behavior of the...
- 17 April 2014 12:48 pm , Vol. 344 , #6181
- About Us
Obama Administration Maintains Bush-Era Travel Limits on NIH
24 April 2009 12:42 pm
Some federal scientists who thought the Bush Administration policy limiting travel to scientific meetings would be changed got a shock this week. Staff at the National Institutes of Health campus in Bethesda, Maryland, were informed that a cap on travel to big meetings imposed under the Bush Administration by the Department of Health and Human Services, will stay in place.
In a 21 April email to staff, NIH official Kenneth Stith explains that HHS is limiting attendance at several meetings this year to 2008 levels to save money. NIH "requested [HHS] to reconsider reductions ... emphasizing the impact to science and training. However, due to the overall push to reduce costs, the decision was made to continue," the memo says. A spreadsheet obtained by ScienceInsider describes the "reductions" for 13 upcoming meetings—including the June meeting of the Endocrine Society, which is in Washington, D.C., a local trip for NIHers. Only 93 of the 178 staff who wanted to attend can go.
Recession or not, the fact that HHS is still dictating travel spending is irksome to many NIH scientists. "We should be allowed to spend our money the way we think is best," says Samuel Cushman, a 30-year NIH veteran.
Another scientist, who sent a postdoc to present a poster at the American Academy of Neurology meeting starting tomorrow in Seattle, but won't attend himself, says he is "so mad about this, it is hard to put it in words."